Method Peptides · Research compound
$15 flat rate on orders under $200.
Allow 7–10 business days before shipment.
Research reference
Product specifications, research context, and handling information.
AOD9604 is a modified peptide fragment derived from the C-terminal region of human growth hormone and studied in adipose-tissue metabolism, lipolysis, fat-oxidation, and energy-balance models. Preclinical research has evaluated its metabolic activity separately from full-length growth hormone, including evidence that it does not bind or activate the growth hormone receptor in the same manner as intact hGH.
≥99% purity. Third-party tested. Sterile vials. Trusted quality.
5mg: 10 vials containing AOD9604 5mg per vial (50mg total per kit)
Kit Contents: 10 vials containing 5mg per vial (50mg total)
Composition: AOD9604 modified hGH C-terminal fragment
Storage: Store lyophilized material in a cool, dry environment. Keep refrigerated after laboratory reconstitution.
For Research Use Only. Not for human consumption, medical use, diagnostic use, or therapeutic use.
